Mitera Biosciences is a biotech innovator using non-invasive skin epigenetics to advance anti-aging insights.
Mitera Biosciences has raised $1.8M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Mitera Biosciences's investors include Cedars Sinai.
Mitera Biosciences is headquartered in Bellevue, United States.
Mitera Biosciences is a biotech innovator using non-invasive skin epigenetics to advance anti-aging insights.
Mitera Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mitera Biosciences — Funding & Investors." VCBacked, December 30, 2025, https://www.vcbacked.co/company/mitera-biosciences. Accessed September 30, 2026.
VCBacked. (2025). Mitera Biosciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/mitera-biosciences
{{cite web |title=Mitera Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/mitera-biosciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated